Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CP.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.422NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.198NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20237.1US
B.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.416NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.263NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.135NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.219NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.208NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.125.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.78 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.237NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBNNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.356NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.462NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.147NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used